The increasing understanding of the molecular mechanisms leading to the AGE–RAGE-mediated neurological disorders has broadly impacted the design of RAGE inhibitors and antagonists for the treatment of neurological disorders and other RAGE-related diseases. Here, AGER is linked to nervous system disorder.